Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeevan Kumar

Showing results (151-160 of 155) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 155 results.
Journal of Computer-Aided Molecular Design|July 14, 2025
"Heptadecanol" a phytochemical multi-target inhibitor of SMYD3 & GFPT2 proteins in non-small cell lung cancer: an in-silico & in-vitro investigationLokesh Ravi, Pratishtha Jain, Ajith Kumar K, et al.
JACC. Advances|April 28, 2026
Postdilation Strategies Following Provisional Stenting of Left Main Coronary Bifurcations: Insights From Patient-Specific Computational SimulationsShijia Zhao, Wei Wu, Changkye Lee, et al.
European Journal of Human Genetics : EJHG|December 19, 2023
De novo variants underlying monogenic syndromes with intellectual disability in a neurodevelopmental cohort from IndiaShruti Pande, Purvi Majethia, Karthik Nair, et al.
Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine|August 12, 2024
Factors Affecting Survival in Severe and Very Severe COPD after Admission in ICUs of Tertiary Care Centers of India (FAST COPD): Study Protocol for a Multicentric Cohort StudySumalatha Arunachala, Sindhuja Devapal, Dayana Shre N Swamy, et al.
Lancet (London, England)|November 15, 2020
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trialSebastian Grosicki, Maryana Simonova, Ivan Spicka, et al.
Pageof 16

Showing results (151-160 of 155) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 155 results.
Journal of Computer-Aided Molecular Design|July 14, 2025
"Heptadecanol" a phytochemical multi-target inhibitor of SMYD3 & GFPT2 proteins in non-small cell lung cancer: an in-silico & in-vitro investigationLokesh Ravi, Pratishtha Jain, Ajith Kumar K, et al.
JACC. Advances|April 28, 2026
Postdilation Strategies Following Provisional Stenting of Left Main Coronary Bifurcations: Insights From Patient-Specific Computational SimulationsShijia Zhao, Wei Wu, Changkye Lee, et al.
European Journal of Human Genetics : EJHG|December 19, 2023
De novo variants underlying monogenic syndromes with intellectual disability in a neurodevelopmental cohort from IndiaShruti Pande, Purvi Majethia, Karthik Nair, et al.
Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine|August 12, 2024
Factors Affecting Survival in Severe and Very Severe COPD after Admission in ICUs of Tertiary Care Centers of India (FAST COPD): Study Protocol for a Multicentric Cohort StudySumalatha Arunachala, Sindhuja Devapal, Dayana Shre N Swamy, et al.
Lancet (London, England)|November 15, 2020
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trialSebastian Grosicki, Maryana Simonova, Ivan Spicka, et al.
Pageof 16